mynth
← DATABASE
09/2020MajorityLBO

EQT Partners takes majority stake in Colisée

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €1–10bn

Context

EQT Infrastructure entered into exclusive negotiations with IK Investment Partners to acquire a majority stake in Colisée, marking a transition from private equity to infrastructure ownership. IK had previously acquired Colisée in 2017 from Eurazeo PME and the founding family. EQT is deploying capital from its fifth generation infrastructure fund — the largest infrastructure fund ever raised in Europe. The transaction is advised by Lazard on the seller side. EQT has stated its intention to support Colisée's continued growth into new geographic markets following closing.

Previously, the company had already undergone several LBOs, notably led by Eurazeo in 2014 and EQT Partners in 2017. These multiple LBO cycles, coupled with several external growth operations, illustrate the strong appeal for this type of asset.

Colisée, which reported an EBITDA margin of [members only] in 2020, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average observed in the Healthcare & Pharma sector (14.6x in 2020).

-> Deep-dive in Healthcare & Pharma market trends

Target

Colisée is the fourth largest French EHPAD operator, founded in 1976 and chaired by Christine Jeandel. The group operates numerous establishments across France, Spain, Belgium, Italy, and China. Colisée has grown significantly through an active buy-and-build strategy. Colisée is recognised as one of the leading pan-European elderly care platforms, combining a strong French domestic base with meaningful international operations across Southern Europe and Asia.

Ent. Value

€1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2020
€1–10bn
€100–200M
[members only]
2019
€1–10bn
€100–200M
[members only]

Other operations with Colisée

Other operations with Colisée
DateAcquirerTargetCountrySector
04/2019COLISÉEARMONEABELGIUMNursing Homes
04/2017EQT PARTNERSCOLISÉEFRANCENursing Homes
09/2014EURAZEOCOLISÉEFRANCENursing Homes

Other operations with EQT Partners

Other operations with EQT Partners
DateAcquirerTargetCountrySector
10/2026EQT PARTNERSQIAGENGERMANYDiagnostic Equipment
10/2026EQT PARTNERSCLEANAWAYAUSTRALIACollection & Recycling
09/2026EQT PARTNERSMCGILL AND PARTNERSUNITED KINGDOMStrategy & Management
07/2026EQT PARTNERSORIKANAUSTRALIAIoT & Connected Objects
07/2026EQT PARTNERSCOPIA POWERUNITED STATESSolar / PV
06/2026EQT PARTNERSINTERTEKUNITED KINGDOMTIC (Testing, Inspection, Certification)
03/2026EQT PARTNERSKELDA HOLDINGSUNITED KINGDOMWater
07/2025EQT PARTNERSADEVINTA SPAINSPAINE-commerce & Marketplaces
03/2025EQT PARTNERSFORTNOXSWEDENERP, HR & Finance
04/2024EQT PARTNERSUNIVERSIDAD EUROPEASPAINEducation Providers

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
10/2020KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERSELSANFRANCEClinics / Hospitals
10/2020INFRATILQSCAN GROUPAUSTRALIARadiology
09/2020VAM INVESTMENTSDEMENEGOITALYOphthalmology
07/2020ORPEABRINDLEY HEALTHCAREIRELANDNursing Homes
07/2020BIOGROUPLABORIZONFRANCELabs (Biology)
06/2020ASKLEPIOS KLINIKENRHÖN-KLINIKUMGERMANYClinics / Hospitals
03/2020ORPEATLC GROUPIRELANDNursing Homes
02/2020VIVALTO VIESOLIMARSPAINNursing Homes
02/2020AMUNDI PRIVATE EQUITY / SOCIETE GENERALE CAPITAL PARTENAIRESVIVALTO VIEFRANCENursing Homes
02/2020CLARIANEINICEAFRANCEClinics / Hospitals

REFERENCES

Valuation range: EV €1–10bn

Revenue range: €1–10bn

EBITDA range: €100–200M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Colisée by EQT Partners are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: eqt partners

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Colisée, a French company specialised in Healthcare Facilities, by EQT Partners in 2020, structured as a leveraged buyout (LBO). This followed an earlier holding cycle initiated in April 2017, when the company was acquired by EQT Partners.

How was the acquisition of Colisée by EQT Partners valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €1–10bn band, its EV/EBITDA multiple within the 15x - 25x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Colisée’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Colisée generated annual revenue estimated in the €1–10bn range and EBITDA in the €100–200M bracket (FY 2020). Detailed financial figures are available to members.

How does the valuation of Colisée compare to benchmarks in the Healthcare & Pharma sector?

With an estimated valuation multiple in the range of 15x - 25x, Colisée trades above the median sector multiple of 14.6x observed for the Healthcare & Pharma sector in 2020. The descriptive comparison is based on 15 transactions with available EV/EBITDA multiples from differences in size, growth, profitability that may affect comparability.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.